Advanced search
Publication Cover
Cancer Investigation Volume 18, 2000 - Issue 5
Submit an article Journal homepage
22
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Interferon Alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer

Original Article

Andrew Jacobs Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington
,
Philip Gold Department of Medical Oncology, University of Washington, Seattle, Washington
,
Paul Weiden Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington
,
David Aboulafia Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington
,
Robert Rudolph Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington
,
Vincent Picozzi Section of Hematology/Oncology, Virginia Mason Medical Center, Seattle, Washington
&
John Thompson Department of Medical Oncology, University of Washington, Seattle, Washington
 show all
Pages 417-421 | Published online: 11 Jun 2009

References

  • Parker SL, Tong T, Bolden S, et al: Cancer stattstics. CA Cancer J Clmtctans 47: 5–27, 1997.
  • Lmehan WM, Shtpley WU, Parkmson DR: Renal carcmoma. In: Cancer Principles and Practice of Oncology, 5th ed., edtted by VT DeVtta Jr, Hellman S, Rosenberg, SA Philadelphia, Lippincott-Raven, 1997, pp. 1271–1280.
  • Umeda T, Niijima T. Phase II study of alpha interferon on renal cell carcinoma: summary of three collaborative trials. Cancer 1986; 58: 1231–1235
  • Minasian L M, Motzer R J, Gluck L. Interferon alpha-2a in advanced renal cell carcinoma. J Clin Oncol 1993; 11: 1368–1375
  • DeKernion J, Sarna G, Figlin R. The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 1983; 130: 1063–1066
  • Quesada J R, Swanson D A, Trindale A. Renal cell carcinoma; anti-tumor effects of alpha-interferon. Cancer Res 1983; 43: 940–947
  • Quesada J R, Swanson D A, Gutterman J U. Phase II study of interferon alpha in metastatic renal cell carcinoma. S. Clin Oncol 1985; 3: 1086–1092
  • Kirkwood J M, Harris J E, Vera R. Randomized study of low and high doses of leukocyte alpha interferon in metastatic renal cell carcinoma. Cancer Res 1985; 45: 863–871
  • Figlin R A, DeKernion J B, Mukamel E. Recombinant interferon alpha-2a in metastatic renal cell carcinoma. J Clin Oncol 1988; 6: 1604–1610
  • Neidhart J A, Gagen M M, Young D. Interferon-alpha treatment of renal cell cancer. Cancer Res 1994; 44: 4140–4143
  • Lippman S M, Parkinson D R, Itri L M. 13-cis-Retinoic acid and interferon-alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235–241
  • Lippman S M, Cavanagh J J, Paredes-Espinoza M. 13-cis-Retinoic acid plus interferon-alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992; 84: 241–245
  • Motzer R J, Schwartz L, Law T M. Interferon alpha-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro. J Clin Oncol 1950–1957; 13, 1995
  • Miller A B, Hoogstraten B, Staquet M. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
  • Gehan E A. The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent. J Chronic Dis 1961; 13: 346–353
  • Berg W J, Schwartz L H, Amsterdam A. A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma. Invest New Drugs 1997; 15: 353–355
  • Leung A CF, Nanus D M, Mamazumdar M. Retinoic acid receptor-β (RAR-β) expression in renal cell carcinoma (RCC) of patients treated with interferon-alfa-2a (IFN) and 13-cis-retinoic acid (CRA): correlation with clinical response. Proc ASCO 1997; 16: 1203
  • Muss H B. Interferons—clinical applications: renal cell carcinoma. Biologic Therapy of Cancer, VT De Vita, S Hellman, SA Rosenberg. J.B. Lippincott, Philadelphia 1991; 298–311
  • Yagoda A, Abi-Rached B, Petrylak D. Chemotherapy for advanced renal cell carcinoma: 1983–1993. Semin Oncol 1995; 22: 42–60
  • Fyfe G, Fisher R I, Rosenberg S A. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 1995; 13: 688–696
  • Stadler W M, Vogelzang N J. Low-dose interleukin-2 in the treatment of metastatic renal cell carcinoma. Semin Oncol 1995; 22: 67–73
  • Stadler W M, Kuzel T, Dumas M. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma. J Clin Oncol 1998; 6: 1820–1825
  • Negrier S, Escudier B, Lasset C. Recombinant human interleukin-2, recombinant human interferon-alpha-2a, or both in metastatic renal cell carcinoma. N Engl J Med 1998; 338: 1272–1278
  • Gleave M, Elhilali M, Faradet Y. Interieron-gamma-1 b compared with placebo in metastatic renal-cell carcinoma. N Engl J Med 1998; 338: 1265–1271
  • Bukowski M, Sharfman W, Murthy S. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin-2 in human metastatic renal-cell carcinoma. Cancer Res 1991; 51: 4199–4205
  • Pierce W, Belldegrun A, Figlin R. Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renalcell cancer. Semin Oncol 1995; 22: 74–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.